Cardiac arrest & resuscitation

Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management

Crit CarePublished Prospective observational study

Authors' conclusion

Novel serum biomarkers reliably predicted poor neurological outcomes for patients with OHCA treated with TTM when life-sustaining therapy was not withdrawn.

Study context

Population
Out-of-hospital cardiac arrest (OHCA) patients treated with TTM, biomarkers measured at 0, 24, 48 and 72 h after ROSCAugust 2018 to May 2020
Participants
100 patients
Exposure
Novel (tau, NFL, glial fibrillary acidic protein (GFAP), UCH-L1) vs conventional (NSE, S-100B) serum biomarkers for predicting poor neurological outcome
Outcome
Poor neurological outcome
Follow-up
6 months after OHCA
Methodological detailsdiagnostic/prognostic accuracy, SIMOA immunoassay
  • Diagnostic/prognostic accuracy
  • SIMOA immunoassay

Main finding

As reported in the abstract

Prediction of poor neurological outcome (AUC at 72 h after CA) · 72 h after CA
GroupAUCSensitivity (95% CI 59.9-89.6)Specificity
Tau0.906— not stated in the abstract— not stated in the abstract
NFL0.94677.1%100%
GFAP0.875— not stated in the abstract— not stated in the abstract
UCH-L10.935— not stated in the abstract— not stated in the abstract

AUC

Tau0.906
NFL0.946
GFAP0.875
UCH-L10.935

Sensitivity (95% CI 59.9-89.6)

Tau— not stated in the abstract
NFL77.1%
GFAP— not stated in the abstract
UCH-L1— not stated in the abstract

Specificity

Tau— not stated in the abstract
NFL100%
GFAP— not stated in the abstract
UCH-L1— not stated in the abstract

— not stated in the abstract

All conventional and novel serum biomarkers discriminated between good and poor neurological outcome groups
P < 0.001

Observational data: associations, not effects.

Original publication

Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management. Crit Care. Published 16 March 2023. doi:10.1186/s13054-023-04400-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.